Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
about
The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairmentMitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionBlood markers of oxidative stress in Alzheimer's diseaseNeuroinflammation in Alzheimer's diseaseRedox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition.NADPH oxidase as a therapeutic target in Alzheimer's disease.Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobuleIntraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer diseasePreclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.Conformational altered p53 as an early marker of oxidative stress in Alzheimer's diseaseEpigenomics of Alzheimer's disease.Oxidative stress in Alzheimer disease: synergy between the Butterfield and Markesbery laboratories.Effects of GSTM1/GSTT1 gene polymorphism and fruit & vegetable consumption on antioxidant biomarkers and cognitive function in the elderly: a community based cross-sectional studyOxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2.Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.Impaired mitochondrial energy metabolism as a novel risk factor for selective onset and progression of dementia in oldest-old subjects.Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.Selective chemoprecipitation to enrich nitropeptides from complex proteomes for mass-spectrometric analysisEffects of APOE rs429358, rs7412 and GSTM1/GSTT1 Polymorphism on Plasma and Erythrocyte Antioxidant Parameters and Cognition in Old Chinese Adults.Synergistic Interaction of Light Alcohol Administration in the Presence of Mild Iron Overload in a Mouse Model of Liver Injury: Involvement of Triosephosphate Isomerase Nitration and InactivationLoss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stressTyrosine-lipid peroxide adducts from radical termination: para coupling and intramolecular Diels-Alder cyclization.Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer diseaseNatural antioxidants in Alzheimer's disease.Sublethal RNA oxidation as a mechanism for neurodegenerative diseaseIntermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's diseaseProteomics of human neurodegenerative diseasesProteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study.Nanoscale Particulate Matter from Urban Traffic Rapidly Induces Oxidative Stress and Inflammation in Olfactory Epithelium with Concomitant Effects on Brain.Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease.
P2860
Q26827320-859E864A-6D49-474B-A29A-816AC3BB4094Q26865358-35BF663D-50D5-475D-B544-0D9EDD1B2869Q27021625-D9770B75-19D9-4B57-BF67-81BB6F31103EQ28259238-FC771E65-29AF-4DBB-BA0D-66ABCD5BB791Q30367032-1C05E88C-6581-43D9-ABAB-A9C319C2B187Q30490908-8C5284C5-2C96-404B-8AC9-D9BFA6949F96Q30855129-9ECF507B-1174-486B-8FC6-60DE2C55F8A6Q33506441-DDB6C73B-F9A2-4D11-9CA2-F5441424ACC5Q33643522-9788335D-90AD-46AE-8481-15C72025A192Q33674631-61D6F2FB-C217-46C0-BA6C-6D5397651509Q33707944-8B955D4C-802D-49A2-8724-74F9605E251AQ33857238-8A353DC0-7E38-4101-B249-D4ED76F6134AQ33912803-45B512E0-BF8B-47C9-BE12-BA8A28908D84Q34094516-45D92C96-D0E1-4CFA-A356-4212013211C0Q34126651-415C1A9F-DE8E-4766-A584-129F8E3D6F40Q34518584-12D40529-E0B7-4C26-9891-6BDB14C43BBDQ34561160-7342AA39-7F31-4C50-A92E-4E3A731994BEQ34566174-57B30756-2784-4BBF-9CB5-FB9FAFD75ACCQ34570989-A8CCC00C-DCE8-4727-8193-C9529038173CQ34994270-4CA8105A-7E68-476F-B3A3-79B1A7B6C6A8Q35168684-C086B777-00A8-4A8E-8C27-4307D7AA7A3EQ35677159-16230F99-223E-46E6-AA74-AEE9C0A4A563Q35783379-9EF8E2BD-E0EF-4F22-8822-8E5D8ACF9F98Q36026546-32057247-F720-4C42-B1D3-FFFDBC42C360Q36076365-11DB091B-B0D0-429A-A7B3-C14CEEEA4ABEQ36126099-A8AADE51-0B41-4444-AFF7-F767E801DB77Q36246699-137EC9F6-059D-40C8-96EA-C09174227AE4Q36253995-8DF9EEB8-7670-4D87-B431-4727316F768AQ36538283-EC5A0E76-66DC-4113-AD71-7CA7081B9E21Q36767908-5A552926-F415-4C5E-8DCF-FE4FB8868B0FQ36916720-77011104-DB73-4A03-92B1-3A6AC17D6782Q36984455-DD1813F5-CDE7-4D22-8567-8722F25AEB57Q37016092-363D9AED-8DF1-45D4-9BBA-BC25860E0898Q37083453-2622EA2B-256B-4B15-9B00-F09BC753E468Q37106933-9BF14005-5BBA-4C15-B480-7515B22AACF1Q37139242-1C0D14FA-23FE-4B61-A42E-55FC3E3FF769Q37260477-54F02066-6393-4964-B882-439546EDCF78Q37295665-5D650B3C-DE04-4C43-921D-AF423DA83631Q37306088-C36567B7-56E9-4E53-A6D9-BB30F2CC05ECQ37361122-1EEC0191-847F-44CB-8CE9-C39F9AFB57AA
P2860
Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Elevated levels of 3-nitrotyro ...... ession of Alzheimer's disease.
@ast
Elevated levels of 3-nitrotyro ...... ession of Alzheimer's disease.
@en
type
label
Elevated levels of 3-nitrotyro ...... ession of Alzheimer's disease.
@ast
Elevated levels of 3-nitrotyro ...... ession of Alzheimer's disease.
@en
prefLabel
Elevated levels of 3-nitrotyro ...... ession of Alzheimer's disease.
@ast
Elevated levels of 3-nitrotyro ...... ession of Alzheimer's disease.
@en
P2093
P2860
P50
P1433
P1476
Elevated levels of 3-nitrotyro ...... ression of Alzheimer's disease
@en
P2093
Carlo De Marco
D Allan Butterfield
Marzia Perluigi
Rukhsana Sultana
William R Markesbery
P2860
P304
P356
10.1016/J.BRAINRES.2007.02.084
P407
P577
2007-03-07T00:00:00Z